Skip to content

Clinical observation on Cognitive Disorder after Cerebral Infarction after limb Ischemia

Protective effect and Mechanism of limb Ischemia Post-treatment on Cognitive Disorder after Cerebral Infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015231
Enrollment
Unknown
Registered
2018-03-16
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment after cerebral infarction

Interventions

Experimental group:limb ischemia postconditioning+conventional neuroprotective treatment
control group:conventional neuroprotective treatment

Sponsors

Henan Province People's Hospital of Internal Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. all patients met the criteria for the diagnosis of cerebral infarction [21] and confirmed on diffusion-weighted magnetic resonance imaging (DWI) that there was a new lesion; 2. Aged 40 to 80 years old; 3. with onset within 72 hours, first onset, or re-onset, but a mRS score of 0-1 before the onset of the disease. Previous sequelae did not affect the neurological function score; 4. patients and their families had signed informed consent after informed consent.

Exclusion criteria

Exclusion criteria: 1. intracerebral hemorrhage or other active hemorrhagic diseases; 2. within 72 hours of thrombolytic therapy by arterial or venous thrombolytic; 3. therapy: previous history of arteriovenous malformation, internal carotid aneurysm, history of brain neoplasms, history of brain surgery, Severe heart failure, acute myocardial infarction; 4. pericarditis, infective endocarditis or suspected infective emboli, aneurysms of the heart wall, Ventricular Thrombosis etc.; 5. severe liver or kidney diseases: malignant neoplasms; systemic organ failure; 6. Clinical examination: unconscious NIHSS > 25; severe aphasia, severe aphasia, severe aphasia, Unable to express yourself; 7. dementia or mental illness; 8. pregnancy; 9. MRI contraindications; 10. blood glucose 22 mmol/L; 11. blood pressure > 200/110 mmHg or < 90/60 mm Hg1; 12. can't be combined with the Montreal cognitive Assessment scale and the MMSE scale to evaluate the limbs; 13. Poor compliance with post-treatment or failure to provide informed consent; 14. Refusal of regular treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
infarct volume;National Institute of Health stroke scale;mRS;stroke cases;Death;

Countries

China

Contacts

Public ContactZHAO Jianhua

Henan Province People's Hospital of Internal Medicine

sjnk2011@163.com+86 13937103138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026